These effects, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the principle of concentrating on ACKR3 as a unique way to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked disorders. Importantly, these receptors were https://jacquesv681zws1.blog-ezine.com/profile